Jul 25, 2023 4:05pm EDT OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023
Jun 28, 2023 11:30am EDT FDA Approves Pfizer’s NGENLA™, a Long-Acting Once-Weekly Treatment for Pediatric Growth Hormone Deficiency
May 03, 2023 4:05pm EDT OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results
Mar 08, 2023 8:00am EST OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate
Feb 23, 2023 4:05pm EST OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results
Feb 16, 2023 11:41am EST OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023
Nov 08, 2022 4:05pm EST OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results